KARUNA THERAPEUTICS INC filings

SEC filings by KARUNA THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14PRICE T ROWE ASSOCIATES INC /MD/Karuna Therapeutics, Inc.1,963,9575.2%EDGAR
SC 13G2024-02-14T. Rowe Price Investment Management, Inc.Karuna Therapeutics, Inc.2,709,6297.2%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCKaruna Therapeutics, Inc.3,224,7868.6%EDGAR
SC 13G/A2024-02-12FMR LLCKaruna Therapeutics, Inc.858,9442.3%EDGAR
SC 13G/A2024-02-12Capital International InvestorsKaruna Therapeutics, Inc.448,8661.2%EDGAR
SC 13G/A2024-02-09Capital International InvestorsKaruna Therapeutics, Inc.4,314,38411.4%EDGAR
SC 13G2024-01-31BlackRock Inc.Karuna Therapeutics, Inc.2,015,3745.3%EDGAR
SC 13G/A2024-01-10FMR LLCKaruna Therapeutics, Inc.2,865,9947.6%EDGAR
SC 13G/A2023-07-07BlackRock Inc.Karuna Therapeutics, Inc.1,864,3185.0%EDGAR
SC 13D/A2023-06-21Sofinnova Venture Partners X, L.P.Karuna Therapeutics, Inc.1,372,4413.7%EDGAR
SC 13G2023-06-09Capital International InvestorsKaruna Therapeutics, Inc.3,838,74010.3%EDGAR
SC 13G/A2023-02-14PRICE T ROWE ASSOCIATES INC /MD/Karuna Therapeutics, Inc.2,363,3046.9%EDGAR
SC 13G/A2023-02-09FMR LLCKaruna Therapeutics, Inc.5,152,98915.0%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCKaruna Therapeutics, Inc.2,753,5438.0%EDGAR
SC 13D/A2023-02-06Sofinnova Venture Partners X, L.P.Karuna Therapeutics, Inc.1,772,4415.2%EDGAR
SC 13G/A2023-01-31BlackRock Inc.Karuna Therapeutics, Inc.2,403,4137.0%EDGAR
SC 13D/A2022-09-20ARCH Venture Fund IX, L.P.Karuna Therapeutics, Inc.--EDGAR
SC 13D/A2022-08-12PureTech Health LLCKaruna Therapeutics, Inc.1,531,5644.6%EDGAR
SC 13D/A2022-08-10PureTech Health LLCKaruna Therapeutics, Inc.1,531,5645.1%EDGAR
SC 13G/A2022-02-14PRICE T ROWE ASSOCIATES INC /MD/Karuna Therapeutics, Inc.1,955,3666.6%EDGAR